Cormorant Asset Management, LP
Position in AMLX — Amylyx Pharmaceuticals, Inc.
CIK 1583977
BOSTON, MA
Position in AMLX
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$4,865,000
+$33,000 QoQ
Shares Held
350,000
-12.5% QoQ
Ownership
0.315%
of shares outstanding
% of Portfolio
0.25%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Sep 2022
5 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in AMLX Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Mar 31, 2026Cormorant Asset Management, LP holds $55,421,681 across 2 Drug Manufacturers - Specialty & Generic names. AMLX ranks #2 (8.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | BIOA |
BioAge Labs, Inc.
|
2,890,605 | $50,556,681 | |
| 2 | AMLX |
Amylyx Pharmaceuticals, Inc.
This page
|
350,000 | $4,865,000 |
All Filings in AMLX
Export CSV
5 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $4,865,000 | 350,000 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $4,832,000 | 400,000 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $6,795,000 | 500,000 | Shares | Defined | 2025-11-14 | |
| 2022-12-31 | $20,322,500 | 550,000 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $17,171,500 | 610,000 | Shares | Defined | 2022-11-14 | |
| No filing history on record for this holder in this stock. | ||||||